Skip to main content

Table 4 Intervention outcomes for clinical endpoints

From: Impact of pharmacist-led aminoglycoside stewardship: a 10-year observational study

 

Before intervention

N = 123

After intervention

N = 140

P-value

Clinical efficacy

Effective

80 (65%)

99 (71%)

P = 0.35a

Not effective

30 (24%)

29 (21%)

 

Unnecessary use

13 (11%)

12 (8.6%)

 

Adverse events

Renal impairmentb

13 (11%)

17 (12%)

P = 0.85

Discontinuation due to adverse events

6 (4.9%)

10 (7.1%)

P = 0.61

Kidney injury

5 (4.1%)

3 (2.1%)

P = 0.48

Ototoxicity

0 (0%)

1 (0.7%)

P = 1.00

Skin rash

0 (0%)

2 (1.4%)

P = 0.50

Hepatic injury

0 (0%)

2 (1.4%)

P = 0.50

Diarrhea

1 (0.8%)

0 (0%)

P = 0.47

Loss of appetite

0 (0%)

1 (0.7)

P = 1.00

Death

6 (4.9%)

5 (3.6%)

P = 0.76

  1. a Comparison between effective and other items
  2. b Cases, wherein renal function was measured before and after the use of aminoglycosides (115 patients before intervention and 127 patients after intervention) were targeted